podophyllotoxin has been researched along with Cytokine Release Syndrome in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gohar, UF; Jamshed, I; Manea, R; Moga, M; Mukhtar, H; Mushtaq, A; Popovici, B; Shah, Z; Toma, SI; Zia-Ui-Haq, M | 1 |
1 review(s) available for podophyllotoxin and Cytokine Release Syndrome
| Article | Year |
|---|---|
Podophyllotoxin: History, Recent Advances and Future Prospects.
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Antineoplastic Agents, Phytogenic; COVID-19 Drug Treatment; Cytokine Release Syndrome; Drug Discovery; Drug Repositioning; Humans; Neoplasms; Podophyllotoxin; Podophyllum | 2021 |